Literature DB >> 15633407

Circumscribed choroidal hemangiomas: long-term visual prognosis.

J J Augsburger1, J A Shields, K P Moffat.   

Abstract

Twenty-one patients with a circumscribed choroidal hemangioma in one eye were followed for various intervals ranging from three years to over nine years after diagnosis. Eighteen of the 21 were treated with xenon arc and/or argon laser photocoagulation to the hemangioma in an attempt to reduce or eliminate a secondary retinal detachment at some point during the follow-up period. Only four of the 21 had visual acuity of 6/12 or better in the involved eye at the time of the most recent follow-up, and 15 of the 21 had visual acuity of 6/60 or worse. Persistent nonrhegmatogenous retinal detachment involving the fovea and degenerative changes in the macular retina secondary to prior retinal detachment accounted for most of the visual impairment in these 21 eyes.

Entities:  

Mesh:

Year:  1981        PMID: 15633407

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Fluorescein angiographic findings and results of laser treatment in circumscribed choroidal hemangioma.

Authors:  F Bottoni; D C Tervaert; A F Deutman
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

2.  Application of intravitreal bevacizumab for circumscribed choroidal hemangioma.

Authors:  Min Sagong; Junyeop Lee; Woohyok Chang
Journal:  Korean J Ophthalmol       Date:  2009-06-09

3.  Bilateral circumscribed choroidal hemangioma with retinal and choroidal venous abnormalities.

Authors:  Taiko Fukuda; Noriaki Shimada; Tomoka Ishida; Yuh Furuse; Hideaki Tobita; Kyoko Ohno-Matsui
Journal:  Jpn J Ophthalmol       Date:  2011-09-06       Impact factor: 2.447

4.  Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial.

Authors:  Leandro Chaves; André Messias; Zelia Correa; Rodrigo Jorge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-29       Impact factor: 3.117

5.  [Photodynamic therapy for choroidal hemangioma. Long-term results].

Authors:  S Michels; R Michels; A Beckendorf; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

6.  Morphologic changes of the fovea and visual acuity associated with retinal detachment secondary to circumscribed choroidal hemangioma.

Authors:  Minoru Furuta; Tetsuju Sekiryu; Akihito Kasai; Yasuharu Oguchi
Journal:  Saudi J Ophthalmol       Date:  2013-07

7.  Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma.

Authors:  Subrata Mandal; Prashant Naithani; Pradeep Venkatesh; Satpal Garg
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

Review 8.  Ophthalmic Alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: An Independent Group of Conditions?

Authors:  Solmaz Abdolrahimzadeh; Vittorio Scavella; Lorenzo Felli; Filippo Cruciani; Maria Teresa Contestabile; Santi Maria Recupero
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

Review 9.  Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management.

Authors:  Flavio Mantelli; Alice Bruscolini; Maurizio La Cava; Solmaz Abdolrahimzadeh; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.